NCT00174252 - Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Fetal Growth Retardation

Interventions

DRUG

Genotonorm (Somatropin)

0.40 mg/kg/week dived in 7 daily subcutaneous injections during 2 years

Trial Locations (22)

14033

Pfizer Investigational Site, Caen

25030

Pfizer Investigational Site, Besançon

31000

Pfizer Investigational Site, Toulouse

31026

Pfizer Investigational Site, Toulouse

33000

Pfizer Investigational Site, Bordeaux

35203

Pfizer Investigational Site, Rennes

37044

Pfizer Investigational Site, Tours

49000

Pfizer Investigational Site, Angers

54511

Pfizer Investigational Site, Vandœuvre-lès-Nancy

59019

Pfizer Investigational Site, Lille

59385

Pfizer Investigational Site, Dunkirk

65000

Pfizer Investigational Site, Tarbes

67098

Pfizer Investigational Site, Strasbourg

69677

Pfizer Investigational Site, Bron

75571

Pfizer Investigational Site, Paris

75743

Pfizer Investigational Site, Paris

75935

Pfizer Investigational Site, Paris

76000

Pfizer Investigational Site, Rouen

80030

Pfizer Investigational Site, Amiens

87042

Pfizer Investigational Site, Limoges

Unknown

Pfizer Investigational Site, Lorient

06202

Pfizer Investigational Site, Nice